← FDA DRUG APPROVALS

FDA ANDA · ANDA075739

MESNA

Sponsor: HIKMA

APPLICATION
ANDA075739
TYPE
ANDA
ORIGINAL APPROVAL
2004-01-09
LATEST ACTION
2024-07-17
ROUTE
INTRAVENOUS, Injection
DOSAGE FORM
Injectable, INJECTABLE
MARKETING STATUS
Prescription

Products

MESNAPrescription
MESNA 1G/10ML · Injectable · Injection
MESNAPrescription
MESNA 100MG/ML · INJECTABLE · INTRAVENOUS

Approval history

2024-07-17Labeling · Supplement 10 · standardAP
2024-07-17Labeling · Supplement 9 · standardAP
2024-07-17Labeling · Supplement 7 · standardAP
2004-01-09OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →